Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06712693 · ClinicalTrials.gov registry record · NA
Venting Effects on Speech Performance
A NA study, sponsored by Sonova.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT06712693 is a NA study that has completed, run by Sonova. The registered enrollment target is 19 participants.
The verdict
NCT06712693, a NA study, has completed, sponsored by Sonova.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This study aims to gather behavioral data on the effect of earmold venting on speech performance in noise with a new noise reduction feature.
Interventions
- DEVICE Phonak Audeo Infinio Hearing Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2024-11-11 |
| Est. Completion | 2025-01-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06712693
The ClinicalTrials.gov registry entry for NCT06712693 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sonova, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Phonak Audeo Infinio Hearing Aid is the first listed.
NCT06712693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06712693 about?
NCT06712693 is a clinical study titled "Venting Effects on Speech Performance". This study aims to gather behavioral data on the effect of earmold venting on speech performance in noise with a new noise reduction feature.
What is the current status of trial NCT06712693?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2024-11-11. Estimated completion is 2025-01-23.
What interventions are being tested in trial NCT06712693?
The interventions under investigation include: Phonak Audeo Infinio Hearing Aid (DEVICE).
Who is sponsoring clinical trial NCT06712693?
This trial is sponsored by Sonova, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.